Parkinson's disease: Diagnosis and management deep dive
These educational modules have been developed with the assistance of Professors Per Odin (Division of Neurology, Lund University, Sweden), Joaquim Ferreira (Professor of Neurology and Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal), K. Ray Chaudhuri (The Maurice Wohl Clinical Neuroscience Institute, King's College London, United Kingdom), Werner Poewe (Department of Neurology, Medical University of Innsbruck, Austria), and Cleanthe Spanaki (Department of Neurology, University of Crete - School of Medicine, Heraklion, Greece). This activity was supported by AbbVie.
The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.
For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the approved product labelling for your country/region. Please note that products may have different product labelling according to geographical location.
All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental.
This activity is intended only for healthcare professionals registered to practise in one of the following countries:
Australia, Austria, Belgium, Bulgaria, Canada, Germany, Greece, Israel, Italy, Kuwait, Netherlands, Oman, Poland, Portugal, Qatar, Romania, Saudi Arabia, Spain, United Arab Emirates
To proceed, please confirm that you are a healthcare professional practising in one of the aforementioned countries.
Modules
Theme 1: Early identification of patients with PD inadequately controlled by medication
Theme 2: Concept of continuous dopaminergic stimulation
Theme 3: Patient profiles for device aided therapies
Theme 4: Efficacy and safety of device-aided therapies
Theme 5: Challenges in advanced Parkinson’s disease
